Patrick Mayes Sells 2,207 Incyte Corp Shares at $123.99 Each

On August 9, 2026, Patrick Mayes, EVP and Chief Scientific Officer of Incyte Corp, sold 2,207 shares of Incyte Corp at $123.99 each, totaling $273,645.

Who is Patrick Mayes and What is His Real Role at Incyte Corp

Patrick Mayes is the EVP and Chief Scientific Officer of Incyte Corp, a company specializing in research and development of medical treatments. As part of the leadership team, he has access to privileged information about the company, including research projects and financial results. His role is crucial for strategic decision-making and steering the company.

As Chief Scientific Officer, Patrick Mayes is responsible for directing the company's research and development activities. He collaborates closely with research teams to identify opportunities for developing new treatments and oversees clinical trials. His scientific expertise and experience are essential for the company's success.

As part of the leadership team, Patrick Mayes also has responsibilities in terms of management and strategic planning. He participates in decisions regarding resource allocation, goal setting, and implementing business plans. His role is both scientific and strategic, giving him a comprehensive view of the company and its activities.

Transaction Details: 2,207 shares at $123.99 each

The transaction carried out by Patrick Mayes on August 9, 2026, concerns the sale of 2,207 Incyte Corp shares at $123.99 each. The total value of the transaction is $273,645. It is important to note that the per-share price and the total transaction value are two different figures. The per-share price is $123.99, while the total transaction value is $273,645.

The date of the transaction is August 9, 2026, and the information source is the SEC EDGAR Form 4, which is a mandatory filing for company executives and board members. This type of filing is required by the Securities and Exchange Commission (SEC) to ensure transparency of transactions carried out by insiders.

Why Insiders Sell Their Shares – Possible Reasons

Insiders, such as Patrick Mayes, may sell their shares for various reasons. One possible reason is portfolio diversification. Insiders may have a significant portion of their wealth invested in their company's shares, exposing them to high risk in case of a stock price decline. By selling part of their shares, they can reduce their exposure and diversify their portfolio.

Another possible reason is tax planning. Insiders may sell their shares to realize capital gains and pay the corresponding taxes. They may also use the funds for other investments or to cover personal expenses.

It is also possible that insiders sell their shares due to concerns about the company's financial health. If they have privileged information about the company's financial results or prospects, they may decide to sell their shares to avoid potential losses. However, it is important to note that insiders are subject to confidentiality rules and cannot use insider information for investment decisions.

How Individual Investors Track Form 4 Filings

Individual investors can track the Form 4 filings made by insiders using the SEC EDGAR resources. T